Maple Syrup Urine Disease
Discover unique market-leading data and insights into the Maple Syrup Urine Disease market. From the latest Maple Syrup Urine Disease industry reports and analysis to comprehensive market growth forecasts, trends and research.
Browse our full list of Maple Syrup Urine Disease market reports here.
- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
- The Price Conversion is only for the Indicative purpose.
- USD — US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
-
Product Insights
Product Insights Maple Syrup Urine Disease – Drugs In Development, 2023 Maple Syrup Urine Disease – Drugs In Development, 2023
$2,000 | January 2024 Global Markets Direct’s, ‘Maple Syrup Urine Disease - Drugs In Development, 2023’, provides an overview of the Maple Syrup Urine Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Maple Syrup Urine Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.